News

4DMT's Upcoming Investor Conferences and Key Developments

4DMT's Upcoming Investor Conferences and Key Developments

4DMT's Participation in Investor Conferences

4D Molecular Therapeutics, known by its ticker symbol Nasdaq: FDMT, is gearing up to engage with investors at several notable conferences. As a pioneering late-stage biotechnology firm, 4DMT is making significant strides in developing therapeutics that are disease-targeted and durable. These advancements hold promise to redefine treatment methodologies and greatly enhance patient outcomes.

Conference Details

BofA Securities 2025 Healthcare Conference

The first of these events is the BofA Securities 2025 Healthcare Conference, where management is set to participate in discussions about the company’s future and offerings.

Presentation Date: May 14, 2025

Presentation Time: 2:20 p.m. PT

The ability for one-on-one interactions at these conferences signifies the company’s commitment to transparency and investor relations. This is an opportunity for investors to understand more about 4DMT’s innovative work and therapeutic prospects.

RBC Capital Markets 2025 Global Healthcare Conference

Following that, 4DMT will take part in the RBC Capital Markets 2025 Global Healthcare Conference.

Presentation Date: May 21, 2025

Presentation Time: 9:00 a.m. ET

Both conferences will provide platforms for the management team to delve into the company’s transformative therapeutic approaches and answer queries from potential investors.

Webcasts and Archives

For those who cannot attend the live sessions, an archive of the webcasts will be accessible on the 4DMT website for a year, allowing for extended reach and engagement with stakeholders.

Company Profile

4D Molecular Therapeutics is at the forefront of biotechnology, specializing in therapies designed to tackle complex diseases with a focus on long-lasting efficacy. The company’s flagship product, 4D-150, is engineered to treat blinding retinal vascular diseases. It incorporates a unique delivery system for anti-VEGF therapies, allowing a single injection to provide multi-year results, thus significantly reducing the need for frequent treatments.

Currently in Phase 3 development, 4D-150 targets wet age-related macular degeneration and has plans for further applications such as managing diabetic macular edema.

In addition, the company has launched its second candidate, 4D-710, a groundbreaking genetic medicine that facilitates targeted delivery of the CFTR gene to the lungs, showing promise for cystic fibrosis patients. This innovation marks a significant milestone in genetic therapies, showcasing 4DMT’s commitment to bringing novel solutions to complex health challenges.

Regulatory Insights

It's important to note that all product candidates from 4D Molecular Therapeutics remain in various stages of clinical and preclinical evaluation. As a responsible entity, the company emphasizes that these therapies have not yet received approval from the relevant regulatory authorities, including the U.S. FDA. The journey towards approvals is both critical and rigorous, ensuring only the safest and most effective therapies reach the market.

Company Contact Information

For more details, media inquiries can be directed to Jenn Gordon at dna Communications via Media@4DMT.com. For investors, key insights can be obtained from Julian Pei, Head of Investor Relations and Corporate Finance, at Investor.Relations@4DMT.com.

Frequently Asked Questions

1. What are the upcoming investor conferences that 4DMT will attend?

4DMT will participate in the BofA Securities 2025 Healthcare Conference on May 14 and the RBC Capital Markets 2025 Global Healthcare Conference on May 21.

2. What is the focus of 4DMT's therapeutics?

4DMT focuses on developing durable, disease-targeted therapeutics for complex diseases, emphasizing long-lasting treatment outcomes.

3. When will the webcasts of the conferences be available?

The webcasts will be archived on the 4DMT website and available for up to one year for interested stakeholders.

4. What is the status of 4DMT's product candidates?

All current product candidates are either in clinical or preclinical stages, still awaiting regulatory approvals.

5. How can investors stay updated on 4DMT?

Investors can stay updated by visiting the 4DMT website and following their official channels for the latest news and developments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

HDD vs SSD: EaseUS Report Shows Alarming Disk Health Trends

Updated Category News Views 74

Disks Under the Microscope: Key Insights from 2026 Report Well, here's a data nugget that'll make you rethink your storage options: EaseUS Software dropped a disk health bombshell with their 2026 report, putting HDDs in the hot seat. Turns out, HDDs are about as trustworthy as a flaky friend, clocking in at 20 times more caution or bad health ratings compared to their...

Continue Reading
Shenzhen Hosts FDI Moot: A Key Milestone for Arbitration

Updated Category News Views 104

Shenzhen Steps into the Arbitration Spotlight In a move that's bound to tweak some eyebrows in the legal realm, Shenzhen just hosted the 2026 Foreign Direct Investment International Arbitration Moot (FDI Moot) Global Finals. This marks the first time the finals have landed on Chinese soil, and folks, that's a big deal. It’s a hefty nod to China's expanding credibility...

Continue Reading
UFP Industries Fortifies Gulf Coast with $27M Buy

Updated Category News Views 84

UFP Industries Makes a Strategic Move Folks, it looks like UFP Industries (NASDAQ: UFPI) is making some solid moves down in the Gulf Coast, and they're shelling out $27 million to do it. This time, they've got their eyes on Apache Products, dba Acme Skid, a company that's been doing the heavy lifting in the pallet manufacturing space in Silsbee, Texas. Apparently, these...

Continue Reading
Surgery Partners Buyout: Fair Deal or Insider Jackpot?

Updated Category News Views 57

What's Going On With Surgery Partners? Alright, here's the scoop that shareholders can't ignore—Surgery Partners (NYSE:SGRY) could be heading under the scalpel itself with a proposed buyout by HealthSpan. For those holding onto SGRY stock, this might feel like watching the rerun of a medical drama where the ending ain't clear yet. Shareholders are set to get $23.50 a...

Continue Reading
SWI Compute's Bold Move: Transforming Power Into AI

Updated Category News Views 173

The Power Play: From Grid to AI If you think turning megawatts into money-making machines is a stretch, think again. SWI Compute is daringly striding into this territory with the launch of its NVIDIA AI factories in Europe, backed by a hefty 3.6 gigawatts of secured power capacity. It's not just talk; they've got the juice, both in electricity and ambition, to boot....

Continue Reading
Ademi LLP Questions RRC Buyout Deal's Fairness

Updated Category News Views 68

Unease Surrounds RRC's Potential Acquisition by EQT Let’s talk about a messy situation brewing with Range Resources Corporation (NYSE: RRC). The lawyers at Ademi LLP are poking around in the shadows of a proposed buyout by EQT Corporation, questioning whether the deal is legit—or if someone’s getting the short end of the stick. It’s all happening in a climate...

Continue Reading
Reimagining Water: A Crisis and a Call to Action

Updated Category News Views 121

Time for a Change The head of the World Water Council, Loïc Fauchon, didn't mince words at the 9th Cairo Water Week. He proclaimed the old methods of water management are sinking under a flood of modern challenges. Toss in climate upheavals, ballooning cities, and unpredictable diets, and you've got yourself a swirling mess that traditional strategies just can’t mop...

Continue Reading
Costa Rican Firms Target Aerospace Supply Chain Gains

Updated Category News Views 0

Today's spotlight swings on a gutsy move by 10 Costa Rican aerospace companies hustling for a foothold on the global stage. These folks aren't just sitting back; they're throwing their hats in the ring at the NBAA-BACE shindig down in the neon glare of Las Vegas, aiming to muscle into the aerospace supply chain — a cold, hard leap that's a mix of grit and ambition....

Continue Reading
Gentex Faces Investigation as Shares Tumble 7%

Updated Category News Views 54

Investigating Gentex's Financial Setback Gentex Corporation, ticker NASDAQ:GNTX, is caught in a bit of a blizzard right now. Their shares took a nosedive, down 7%, after some messy numbers came out in their third-quarter report—tariffs and the kind of pricing pressure that makes grown investors wince. If you threw your chips in on Gentex and got burned, the lawyers are...

Continue Reading
2026 Diamond Certified Directory: A Trustworthy Guide

Updated Category News Views 107

A Refreshing Reality in a Sea of Online Reviews Imagine having a compass that actually points you in the right direction through the foggy mess of online reviews. That's what the Fall 2026 Diamond Certified Directory aims to be. This ain't some random collection of opinions. This is hard-hitting, reliable information that's been battle-tested in the real world. We're...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Consumer Financial Health: Equifax's New Index

Updated Category News Views 200

Equifax Launches Market Pulse Index for Consumer Insights The Market Pulse Index is a new initiative by Equifax, designed to shed light on the financial health of U.S. consumers. This innovative index reflects a variety of key financial components, demonstrating how they interact and evolve in changing economic conditions. With a scale from 1 to 100, wherein 100 indicates...

Continue Reading
Big Tree Cloud Unveils New Equity Incentive Plan for Growth

Updated Category News Views 75

Big Tree Cloud Introduces Equity Incentive Plan Big Tree Cloud Holdings Limited has made significant strides in corporate governance and employee engagement by adopting a new Equity Incentive Plan. This initiative aims to enhance the company’s ability to attract and retain talented individuals within its ranks. By allowing the granting of share options and other...

Continue Reading
Earnings Insights: The Financial Landscape of Major Banks

Updated Category News Views 332

Analyzing the Earnings of Major Banks This article presents a synthesis of the recent earnings reports of major financial institutions, including JPMorgan (JPM), Bank of America (BAC), and Citigroup (C). Each bank's performance offers insights into the current economic environment and highlights their strategic maneuvers in a competitive landscape. JPMorgan's Resilient...

Continue Reading
Radiopharm Theranostics Engages in Major Funding Round of A$40M

Updated Category News Views 280

Radiopharm Theranostics Secures A$35 Million in Fundraising Radiopharm Theranostics Limited, known for its innovative radiopharmaceutical products, is thrilled to announce a successful capital raise of approximately A$35 million. This amount has been gathered through a private placement, attracting new institutional investors both from Australia and abroad. Strategic...

Continue Reading
Projected Growth in the Mouth Freshener Market to USD 36.33B

Updated Category News Views 117

Overview of the Mouth Freshener Market Growth The mouth freshener market is experiencing exciting growth as consumers become more aware of oral hygiene and personal care. Industry experts predict the market will reach an impressive value of USD 36.33 billion by 2035. This significant increase reflects a robust compound annual growth rate (CAGR) of 6.7% between 2025 and...

Continue Reading